BaseSpace™ Clarity LIMS Workflows, Protocols and Step Overview

478 views | 1 year ago

Learn about the three basic tracking entities within BaseSpace™ Clarity LIMS. QB#9720 Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global...

BaseSpace™ Clarity LIMS New Features and Functionalities

526 views | 1 year ago

Learn about the new features in BaseSpace™ Clarity LIMS v5.3. This video will walk you through the improvement in our single web based interface, simplified and expanded configuration, and security...

Illumina Oncology | ctDNA-guided treatment in colorectal cancer

177 views | 1 year ago

Jeanne Tie, MD, discusses the DYNAMIC trial and areas of unmet needs for minimal residual disease (MRD) to become the standard of care for patients with colorectal cancer. The DYNAMIC trial showed that...

Learn How Creighton University is Advancing Cancer Research with the NextSeq 2000

267 views | 1 year ago

Hear from Jun Xia, PhD and Yusi Fu, PhD, co-directors of the Innovative Genomics & Bioinformatics Core (IGBC) at Creighton University, about their cancer research as well as the people who inspire their...

Illumina® | 20 years of innovation in one instrument: The NovaSeq™X Series

71329 views | 1 year ago

For twenty years, we’ve empowered you to make life-changing science. Delivered the tools to fuel breakthrough discoveries. And we’re not stopping there. Because we know the next #genomicbreakthroughs,...

Illumina Oncology - Whole-genome sequencing (WGS) in acute myeloid leukemia (AML)

385 views | 1 year ago

Eric Duncavage, MD, explains how patients with AML can benefit from whole-genome sequencing testing at diagnosis and after treatment for minimal or measurable residual disease (MRD) assessment. Dr....

TruSight™ Oncology 500 HRD at Oncopole Toulouse (France) ft. Dr. Guillaume Bataillon

458 views | 1 year ago

TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer...

TruSight™ Oncology 500 HRD at IRCCS Pascale (Italy) ft. Prof. Nicola Normanno

283 views | 1 year ago

TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer...